India’s race for the CDMO crown
For years, China+1 has been the big story in India's CDMO opportunity. Now, it…
Interviews
How Pivot Path is in a sweet spot to address pharma’s pressure points
Pivot Path emerged from Strides Pharma's internal GCC. Are other pharma companies also following the same playbook? And if so,…
The discipline for next 2-3 years will be to keep growing the base responsibly, not chasing volume
India’s cold-chain logistics sector is witnessing rapid growth, led by rising demand for temperature-sensitive pharmaceuticals,…
Why India’s medicines need integrated authentication, enforceable standards
Triggered by recent high profile operations involving counterfeit semaglutide in the domestic markets and anti-rabies vaccines…
